{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:09:08Z","timestamp":1763507348112,"version":"3.45.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010249"],"award-info":[{"award-number":["2023A1515010249"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Aid Project for Xinjiang","award":["KTPYJ2024013"],"award-info":[{"award-number":["KTPYJ2024013"]}]},{"name":"President Foundation of Zhujiang Hospital, Southern Medical University","award":["yzjj2022ms2"],"award-info":[{"award-number":["yzjj2022ms2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07301-9","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:20:39Z","timestamp":1763464839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative multi-omics and Mendelian randomization identify WWOX and THBS2 as potential therapeutic targets in mature T\/NK-cell lymphoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Yinjie","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayue","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzhi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeqin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5433-364X","authenticated-orcid":false,"given":"Yuxian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"7301_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.20892\/j.issn.2095-3941.2023.0464","volume":"21","author":"J Jia","year":"2024","unstructured":"Jia J, Wang X, Song Z, Meng S, Fei Y, Yu J, et al. A retrospective analysis of mature T- and NK-cell lymphomas. Cancer Biol Med. 2024;21:223\u20139.","journal-title":"Cancer Biol Med"},{"key":"7301_CR2","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1093\/annonc\/mdx316","volume":"28","author":"SH Lim","year":"2017","unstructured":"Lim SH, Hong JY, Lim ST, Hong H, Arnoud J, Zhao W, et al. Beyond first-line non-anthracycline-based chemotherapy for extranodal NK\/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease. Ann Oncol Off J Eur Soc Med Oncol. 2017;28:2199\u2013205.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"7301_CR3","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3324\/haematol.2017.186577","volume":"103","author":"M Bellei","year":"2018","unstructured":"Bellei M, Foss FM, Shustov AR, Horwitz SM, Marcheselli L, Kim WS, et al. The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, international T-Cell project. Haematologica. 2018;103:1191\u20137.","journal-title":"Haematologica"},{"key":"7301_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41392-024-01825-0","volume":"9","author":"Y Gao","year":"2024","unstructured":"Gao Y, He H, Li X, Zhang L, Xu W, Feng R, et al. Sintilimab (anti-PD-1 antibody) plus Chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib\/II study. Signal Transduct Target Ther. 2024;9:121.","journal-title":"Signal Transduct Target Ther"},{"key":"7301_CR5","doi-asserted-by":"publisher","first-page":"101071","DOI":"10.1016\/j.blre.2023.101071","volume":"60","author":"SC Macapagal","year":"2023","unstructured":"Macapagal SC, Bennani NN. Nodal peripheral T-cell lymphoma: Chemotherapy-free management, are we there yet? Blood Rev. 2023;60:101071.","journal-title":"Blood Rev"},{"key":"7301_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41591-024-03326-7","volume":"31","author":"K Cwynarski","year":"2025","unstructured":"Cwynarski K, Iacoboni G, Tholouli E, Menne T, Irvine DA, Balasubramaniam N, et al. TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1\/2 trial. Nat Med. 2025;31:137\u201343.","journal-title":"Nat Med"},{"key":"7301_CR7","first-page":"a041302","volume":"12","author":"E Birney","year":"2022","unstructured":"Birney E. Mendelian randomization. Cold Spring Harb Perspect Med. 2022;12:a041302.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"7301_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.semcancer.2018.04.008","volume":"55","author":"MH Wang","year":"2019","unstructured":"Wang MH, Cordell HJ, Van Steen K. Statistical methods for genome-wide association studies. Semin Cancer Biol. 2019;55:53\u201360.","journal-title":"Semin Cancer Biol"},{"key":"7301_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1161\/CIRCULATIONAHA.118.038814","volume":"140","author":"D Gill","year":"2019","unstructured":"Gill D, Georgakis MK, Koskeridis F, Jiang L, Feng Q, Wei W-Q, et al. Use of genetic variants related to antihypertensive drugs to inform on efficacy and side effects. Circulation. 2019;140:270\u20139.","journal-title":"Circulation"},{"key":"7301_CR10","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1161\/STROKEAHA.120.032617","volume":"52","author":"MK Georgakis","year":"2021","unstructured":"Georgakis MK, Gill D. Mendelian randomization studies in stroke: exploration of risk factors and drug targets with human genetic data. Stroke. 2021;52:2992\u20133003.","journal-title":"Stroke"},{"key":"7301_CR11","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021;53:1712\u201321.","journal-title":"Nat Genet"},{"key":"7301_CR12","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"GTEx Consortium","year":"2020","unstructured":"GTEx Consortium. The GTEx consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369:1318\u201330.","journal-title":"Science"},{"key":"7301_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.tig.2022.08.005","volume":"39","author":"P Kreitmaier","year":"2023","unstructured":"Kreitmaier P, Katsoula G, Zeggini E. Insights from multi-omics integration in complex disease primary tissues. Trends Genet TIG. 2023;39:46\u201358.","journal-title":"Trends Genet TIG"},{"key":"7301_CR14","doi-asserted-by":"publisher","first-page":"D1227","DOI":"10.1093\/nar\/gkad1040","volume":"52","author":"M Cannon","year":"2024","unstructured":"Cannon M, Stevenson J, Stahl K, Basu R, Coffman A, Kiwala S, et al. DGIdb 5.0: rebuilding the drug-gene interaction database for precision medicine and drug discovery platforms. Nucleic Acids Res. 2024;52:D1227\u201335.","journal-title":"Nucleic Acids Res"},{"key":"7301_CR15","doi-asserted-by":"publisher","first-page":"eaag1166","DOI":"10.1126\/scitranslmed.aag1166","volume":"9","author":"C Finan","year":"2017","unstructured":"Finan C, Gaulton A, Kruger FA, Lumbers RT, Shah T, Engmann J, et al. The druggable genome and support for target identification and validation in drug development. Sci Transl Med. 2017;9:eaag1166.","journal-title":"Sci Transl Med"},{"key":"7301_CR16","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa U, Claringbould A, Westra H-J, Bonder MJ, Deelen P, Zeng B, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021;53:1300\u201310.","journal-title":"Nat Genet"},{"key":"7301_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M, Benner C, Hsu Y-H, Richardson TG, et al. Plasma proteomic associations with genetics and health in the UK biobank. Nature. 2023;622:329.","journal-title":"Nature"},{"key":"7301_CR18","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG, CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40:755\u201364.","journal-title":"Int J Epidemiol"},{"key":"7301_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613:508\u201318.","journal-title":"Nature"},{"key":"7301_CR20","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect Estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512\u201325.","journal-title":"Int J Epidemiol"},{"key":"7301_CR21","doi-asserted-by":"crossref","unstructured":"Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan N, Thompson J. A framework for the investigation of pleiotropy in two\u2010sample summary data Mendelian randomization. Stat Med. 2017;36:1783\u2013802.","DOI":"10.1002\/sim.7221"},{"key":"7301_CR22","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10:e1004383.","journal-title":"PLoS Genet"},{"key":"7301_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-02088-w","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu Y, Zeng J, Zhang F, Zhu Z, Qi T, Zheng Z, et al. Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits. Nat Commun. 2018;9:1\u201314.","journal-title":"Nat Commun"},{"key":"7301_CR24","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48:481\u20137.","journal-title":"Nat Genet"},{"key":"7301_CR25","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/s41588-021-00923-x","volume":"53","author":"JL Min","year":"2021","unstructured":"Min JL, Hemani G, Hannon E, Dekkers KF, Castillo-Fernandez J, Luijk R, et al. Genomic and phenotypic insights from an atlas of genetic effects on DNA methylation. Nat Genet. 2021;53:1311\u201321.","journal-title":"Nat Genet"},{"key":"7301_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453\u20137.","journal-title":"Nat Methods"},{"key":"7301_CR27","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov Camb Mass. 2021;2:100141.","journal-title":"Innov Camb Mass"},{"key":"7301_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock vina: improving the speed and accuracy of Docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455\u201361.","journal-title":"J Comput Chem"},{"key":"7301_CR29","doi-asserted-by":"publisher","first-page":"e627","DOI":"10.1002\/cpz1.627","volume":"2","author":"D Rasooly","year":"2022","unstructured":"Rasooly D, Peloso GM, Giambartolomei C. Bayesian genetic Colocalization test of two traits using Coloc. Curr Protoc. 2022;2:e627.","journal-title":"Curr Protoc"},{"key":"7301_CR30","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/bjh.15767","volume":"185","author":"A Flower","year":"2019","unstructured":"Flower A, Xavier AC, Cairo MS. Mature (non-anaplastic, non-cutaneous) T-\/NK-cell lymphomas in children, adolescents and young adults: state of the science. Br J Haematol. 2019;185:418\u201335.","journal-title":"Br J Haematol"},{"key":"7301_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/d41573-022-00120-3","volume":"21","author":"D Ochoa","year":"2022","unstructured":"Ochoa D, Karim M, Ghoussaini M, Hulcoop DG, McDonagh EM, Dunham I. Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs. Nat Rev Drug Discov. 2022;21:551\u2013551.","journal-title":"Nat Rev Drug Discov"},{"key":"7301_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/1535370214561590","volume":"240","author":"MS Schrock","year":"2015","unstructured":"Schrock MS, Huebner K. WWOX: a fragile tumor suppressor. Exp Biol Med Maywood NJ. 2015;240:296\u2013304.","journal-title":"Exp Biol Med Maywood NJ"},{"key":"7301_CR33","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1007\/s00018-014-1724-y","volume":"71","author":"RI Aqeilan","year":"2014","unstructured":"Aqeilan RI, Abu-Remaileh M, Abu-Odeh M. The common fragile site FRA16D gene product WWOX: roles in tumor suppression and genomic stability. Cell Mol Life Sci CMLS. 2014;71:4589\u201399.","journal-title":"Cell Mol Life Sci CMLS"},{"key":"7301_CR34","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1038\/s41467-018-05852-8","volume":"9","author":"R Chang","year":"2018","unstructured":"Chang R, Song L, Xu Y, Wu Y, Dai C, Wang X, et al. Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2\/STAT3 axis. Nat Commun. 2018;9:3486.","journal-title":"Nat Commun"},{"key":"7301_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.canlet.2021.05.010","volume":"513","author":"T Yang","year":"2021","unstructured":"Yang T, Xu R, Huo J, Wang B, Du X, Dai B, et al. WWOX activation by Toosendanin suppresses hepatocellular carcinoma metastasis through JAK2\/Stat3 and Wnt\/\u03b2-catenin signaling. Cancer Lett. 2021;513:50\u201362.","journal-title":"Cancer Lett"},{"key":"7301_CR36","doi-asserted-by":"publisher","first-page":"116790","DOI":"10.1016\/j.bcp.2025.116790","volume":"233","author":"T Yang","year":"2025","unstructured":"Yang T, Zhang S, Nie K, Peng X, Huo J, Fu X, et al. WWOX-mediated p53\/SAT1 and NRF2\/FPN1 axis contribute to toosendanin-induced ferroptosis in hepatocellular carcinoma. Biochem Pharmacol. 2025;233:116790.","journal-title":"Biochem Pharmacol"},{"key":"7301_CR37","doi-asserted-by":"publisher","first-page":"e010422","DOI":"10.1136\/jitc-2024-010422","volume":"12","author":"S Liu","year":"2024","unstructured":"Liu S, Yang S, Xu M, Zhou Q, Weng J, Hu Z, et al. WWOX tuning of oleic acid signaling orchestrates immunosuppressive macrophage polarization and sensitizes hepatocellular carcinoma to immunotherapy. J Immunother Cancer. 2024;12:e010422.","journal-title":"J Immunother Cancer"},{"key":"7301_CR38","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/ajh.27165","volume":"99","author":"SY Ong","year":"2024","unstructured":"Ong SY, Zain JM. Aggressive T-cell lymphomas: 2024: updates on diagnosis, risk stratification, and management. Am J Hematol. 2024;99:439\u201356.","journal-title":"Am J Hematol"},{"key":"7301_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/1476-4598-13-225","volume":"13","author":"R Sun","year":"2014","unstructured":"Sun R, Wu J, Chen Y, Lu M, Zhang S, Lu D, et al. Down regulation of Thrombospondin2 predicts poor prognosis in patients with gastric cancer. Mol Cancer. 2014;13:225.","journal-title":"Mol Cancer"},{"key":"7301_CR40","first-page":"1683","volume":"19","author":"H Jiao","year":"2020","unstructured":"Jiao H, Zeng L, Zhang J, Yang S, Lou W. THBS2, a microRNA-744-5p target, modulates MMP9 expression through CUX1 in pancreatic neuroendocrine tumors. Oncol Lett. 2020;19:1683\u201392.","journal-title":"Oncol Lett"},{"key":"7301_CR41","doi-asserted-by":"publisher","first-page":"a006627","DOI":"10.1101\/cshperspect.a006627","volume":"2","author":"PR Lawler","year":"2012","unstructured":"Lawler PR, Lawler J. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and \u2013\u20092. Cold Spring Harb Perspect Med. 2012;2:a006627.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"7301_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2021.12.025","volume":"528","author":"P Nan","year":"2022","unstructured":"Nan P, Dong X, Bai X, Lu H, Liu F, Sun Y, et al. Tumor-stroma TGF-\u03b21-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin \u03b1v\u03b23\/CD36-mediated activation of the MAPK pathway. Cancer Lett. 2022;528:59\u201375.","journal-title":"Cancer Lett"},{"key":"7301_CR43","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.jhep.2021.07.016","volume":"75","author":"G Carpino","year":"2021","unstructured":"Carpino G, Cardinale V, Di Giamberardino A, Overi D, Donsante S, Colasanti T, et al. Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma. J Hepatol. 2021;75:1377\u201386.","journal-title":"J Hepatol"},{"key":"7301_CR44","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.3390\/ijms25031782","volume":"25","author":"E Corbella","year":"2024","unstructured":"Corbella E, Fara C, Covarelli F, Porreca V, Palmisano B, Mignogna G, et al. THBS1 and THBS2 enhance the in vitro Proliferation, Adhesion, migration and invasion of intrahepatic cholangiocarcinoma cells. Int J Mol Sci. 2024;25:1782.","journal-title":"Int J Mol Sci"},{"key":"7301_CR45","doi-asserted-by":"publisher","first-page":"115455","DOI":"10.1016\/j.biopha.2023.115455","volume":"167","author":"J Huang","year":"2023","unstructured":"Huang J, Wang C, Hou Y, Tian Y, Li Y, Zhang H, et al. Molecular mechanisms of Thrombospondin-2 modulates tumor vasculogenic mimicry by PI3K\/AKT\/mTOR signaling pathway. Biomed Pharmacother Biomedecine Pharmacother. 2023;167:115455.","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"7301_CR46","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/hmg\/ddad022","volume":"32","author":"L Qi","year":"2023","unstructured":"Qi L, Sun B, Yang B, Lu S. CEBPB regulates the migration, invasion and EMT of breast cancer cells by inhibiting THBS2 expression and O-fucosylation. Hum Mol Genet. 2023;32:1850\u201363.","journal-title":"Hum Mol Genet"},{"key":"7301_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13045-020-00858-6","volume":"13","author":"Q Luo","year":"2020","unstructured":"Luo Q, Wang J, Zhao W, Peng Z, Liu X, Li B, et al. Vasculogenic mimicry in carcinogenesis and clinical applications. J Hematol OncolJ Hematol Oncol. 2020;13:19.","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"7301_CR48","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.7150\/thno.69590","volume":"12","author":"H Yang","year":"2022","unstructured":"Yang H, Sun B, Fan L, Ma W, Xu K, Hall SRR, et al. Multi-scale integrative analyses identify THBS2\u2009+\u2009cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma. Theranostics. 2022;12:3104\u201330.","journal-title":"Theranostics"},{"key":"7301_CR49","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12943-024-02180-y","volume":"23","author":"X Zhou","year":"2024","unstructured":"Zhou X, Han J, Zuo A, Ba Y, Liu S, Xu H, et al. THBS2\u2009+\u2009cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K\/AKT activation in colorectal cancer. Mol Cancer. 2024;23:282.","journal-title":"Mol Cancer"},{"key":"7301_CR50","first-page":"1006","volume":"198","author":"E Vergadi","year":"2017","unstructured":"Vergadi E, Ieronymaki E, Lyroni K, Vaporidi K, Tsatsanis C. Akt signaling pathway in macrophage activation and M1\/M2 polarization. J Immunol Baltim Md 1950. 2017;198:1006\u201314.","journal-title":"J Immunol Baltim Md 1950"},{"key":"7301_CR51","doi-asserted-by":"publisher","first-page":"101014","DOI":"10.1016\/j.jhepr.2024.101014","volume":"6","author":"N Zhang","year":"2024","unstructured":"Zhang N, Wu X, Zhang W, Sun Y, Yan X, Xu A, et al. Targeting thrombospondin-2 retards liver fibrosis by inhibiting TLR4-FAK\/TGF-\u03b2 signaling. JHEP Rep Innov Hepatol. 2024;6:101014.","journal-title":"JHEP Rep Innov Hepatol"},{"key":"7301_CR52","doi-asserted-by":"publisher","first-page":"8571","DOI":"10.1038\/s41467-024-52826-0","volume":"15","author":"A Fischer","year":"2024","unstructured":"Fischer A, Albert TK, Moreno N, Interlandi M, Mormann J, Glaser S, et al. Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas. Nat Commun. 2024;15:8571.","journal-title":"Nat Commun"},{"key":"7301_CR53","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/13543784.2017.1291630","volume":"26","author":"JR Espinoza-Zamora","year":"2017","unstructured":"Espinoza-Zamora JR, Labardini-M\u00e9ndez J, Sosa-Espinoza A, L\u00f3pez-Gonz\u00e1lez C, Vieyra-Garc\u00eda M, Candelaria M, et al. Efficacy of hydralazine and valproate in cutaneous T-cell lymphoma, a phase II study. Expert Opin Investig Drugs. 2017;26:481\u20137.","journal-title":"Expert Opin Investig Drugs"},{"key":"7301_CR54","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/MOH.0000000000000519","volume":"26","author":"F Bertoni","year":"2019","unstructured":"Bertoni F, Stathis A. Bromodomain and Extra-Terminal domain inhibitors for lymphoid malignancies. Curr Opin Hematol. 2019;26:273.","journal-title":"Curr Opin Hematol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07301-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07301-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07301-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:05:47Z","timestamp":1763507147000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07301-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7301"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07301-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"type":"electronic","value":"1479-5876"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"14 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study utilized publicly available datasets, which do not require additional ethical approval. All data were accessed in accordance with the respective database policies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed the final version of the manuscript and approve its publication, including any associated images or data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1306"}}